95214 Federal Register / Vol. 89, No. 231 / Monday, December 2, 2024 / Notices 

the Flatirons Bank Employee Stock 

Ownership Plan and Trust, both of 

Boulder, Colorado; to acquire voting 

shares of FBHC Holding Company, and 

thereby indirectly acquire voting shares 

of Flatirons Bank, both of Boulder, 

Colorado. 

2. The Glenn R. Hamilton Trust dated 

November 20, 1998, and Glenn 

Hamilton, trustee, both of Butler, 

Missouri; to join the Hamilton Family 

Control Group, a group acting in 

concert, to retain voting shares of 

Community First Bancshares, Inc., and 

thereby indirectly acquire voting shares 

of Community First Bank, both of 

Butler, Missouri. In addition, Marsha 

Hamilton, Butler, Missouri, to retain 

voting shares and join the Hamilton 

Family Control Group. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Associate Secretary of the Board. 

[FR Doc. 2024–28216 Filed 11–29–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Safety and 

Occupational Health Study Section 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC), within the 

Department of Health and Human 

Services (HHS), is seeking nominations 

for membership on the Safety and 

Occupational Health Study Section 

(SOHSS). SOHSS consists of 20 experts 

in fields associated with occupational 

medicine and nursing, industrial 

hygiene, occupational safety and 

engineering, toxicology, chemistry, 

safety and health education, 

ergonomics, epidemiology, economic 

science, psychology, pulmonary 

pathology/physiology, and social 

science. 

DATES: Nominations for membership on 

SOHSS must be received no later than 

January 31, 2025. Packages received 

after this time will not be considered for 

the current membership cycle. 

ADDRESSES: All nominations should be 

mailed to Dr. Michael Goldcamp, 1095 

Willowdale Road, Morgantown, West 

Virginia 26505 or emailed to 

MGoldcamp@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Michael Goldcamp, Ph.D., Scientific 

Review Officer, Office of Extramural 

Programs, National Institute for 

Occupational Safety and Health, Centers 

for Disease Control and Prevention, 

1095 Willowdale Road, Morgantown, 

West Virginia 26505. Telephone: (304) 

285–5951; Email: MGoldcamp@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are sought for individuals 

who have the expertise and 

qualifications necessary to contribute to 

the accomplishment of the objectives of 

the Safety and Occupational Health 

Study Section (SOHSS). Nominees will 

be selected based on expertise in the 

fields of occupational medicine and 

nursing, industrial hygiene, 

occupational safety and engineering, 

toxicology, chemistry, safety and health 

education, ergonomics, epidemiology, 

economic science, psychology, 

pulmonary pathology/physiology, and 

social science. Members may be invited 

to serve up to four-year terms. Selection 

of members is based on candidates’ 

qualifications to contribute to the 

accomplishment of SOHSS objectives 

(https://www.cdc.gov/faca/committees/ 

sohss.html). 

Department of Health and Human 

Services (HHS) policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on Federal workgroups or 

prior experience serving on a Federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning of and annually during their 

terms. The Centers for Disease Control 

and Prevention (CDC) reviews potential 

candidates for SOHSS membership each 

year and provides a slate of nominees 

for consideration to the Secretary of 

HHS for final selection. HHS notifies 

selected candidates of their 

appointment near the start of the term 

in October 2025, or as soon as the HHS 

selection process is completed. Note 

that the need for different expertise 

varies from year to year and a candidate 

who is not selected in one year may be 

reconsidered in a subsequent year. 

Candidates should submit the 

following items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

D At least one letter of 

recommendation from person(s) not 

employed by HHS. Candidates may 

submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, 

National Institutes of Health, Food and 

Drug Administration). 

Nominations may be submitted by the 

candidate or by the person/organization 

recommending the candidate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–28183 Filed 11–29–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C. 1009(d), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention, pursuant to Public Law 92– 

463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 231 / Monday, December 2, 2024 / Notices 95215 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

CE25–027, Evaluate STEADI-based Fall 

Prevention in Assisted Living Facilities. 

Dates: March 4–5, 2025. 

Times: 10 a.m.–5 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Aisha L. Wilkes, M.P.H., Scientific 

Review Officer, National Center for 

Injury Prevention and Control, Centers 

for Disease Control and Prevention, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341. 

Telephone: (404) 639–6473; Email: 

AWilkes@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–28181 Filed 11–29–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to 5 U.S.C. 1009(d), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended, and the Determination of 

the Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention, pursuant to Public Law 92– 

463. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel; 

(SEP)—TS25–036, Identify and Evaluate 

Potential Risk Factors for ALS. 

Dates: February 25–26, 2025. 

Times: 10 a.m.–5 p.m., EST. 

Place: Web Conference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: 

Carlisha Gentles, Pharm.D., B.C.P.S., 

C.D.C.E.S., Scientific Review Officer, 

National Center for Injury Prevention 

and Control, Centers for Disease Control 

and Prevention, 4770 Buford Highway 

NE, Mailstop S106–9, Atlanta, Georgia 

30341. Telephone: (770) 488–1504; 

Email: CGentles@cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–28182 Filed 11–29–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–6094–N] 

RIN 0938–ZB85 

Medicare, Medicaid, and Children’s 

Health Insurance Programs; Provider 

Enrollment Application Fee Amount for 

Calendar Year 2025 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces a 

$730.00 calendar year (CY) 2025 

application fee for institutional 

providers that are initially enrolling in 

the Medicare or Medicaid program or 

the Children’s Health Insurance 

Program (CHIP); revalidating their 

Medicare, Medicaid, or CHIP 

enrollment; or adding a new Medicare 

practice location. This fee is required 

with any enrollment application 

submitted on or after January 1, 2025, 

and on or before December 31, 2025. 

DATES: The application fee announced 

in this notice is effective on January 1, 

2025. 

FOR FURTHER INFORMATION CONTACT: 

Frank Whelan, (410) 786–1302. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the February 2, 2011 Federal 

Register (76 FR 5862), we published a 

final rule with comment period titled 

‘‘Medicare, Medicaid, and Children’s 

Health Insurance Programs; Additional 

Screening Requirements, Application 

Fees, Temporary Enrollment Moratoria, 

Payment Suspensions and Compliance 

Plans for Providers and Suppliers.’’ This 

rule finalized, among other things, 

provisions related to the submission of 

application fees as part of the Medicare, 

Medicaid, and CHIP provider 

enrollment processes. 

As provided in section 1866(j)(2)(C)(i) 

of the Social Security Act (the Act) and 

in 42 CFR 424.514, ‘‘institutional 

providers’’ that are initially enrolling in 

the Medicare or Medicaid programs or 

CHIP, revalidating their enrollment, or 

adding a new Medicare practice location 

are required to submit a fee with their 

enrollment application. An 

‘‘institutional provider’’ for purposes of 

Medicare is defined at § 424.502 as ‘‘any 

provider or supplier that submits a 

paper Medicare enrollment application 

using the CMS–855A, CMS–855B (not 

including physician and non-physician 

practitioner organizations), CMS–855S, 

or associated internet-based PECOS 

enrollment application.’’ As we 

explained in the February 2, 2011 final 

rule (76 FR 5914), in addition to the 

providers and suppliers subject to the 

application fee under Medicare, 

Medicaid-only and CHIP-only 

institutional providers would include 

nursing facilities, intermediate care 

facilities for persons with intellectual 

disabilities (ICF/IID), and psychiatric 

residential treatment facilities; they may 

also include other institutional provider 

types designated by a State in 

accordance with their approved State 

plan. 

As indicated in § 424.514 and 

§ 455.460, the application fee is not 

required for either of the following: 

• A Medicare physician or nonphysician practitioner submitting a 

CMS–855I. 

• A prospective or revalidating 

Medicaid or CHIP provider— 

++ Who is an individual physician or 

non-physician practitioner; or 

++ That is enrolled as an institutional 

provider in Title XVIII of the Act or 


ddrumheller on DSK120RN23PROD with NOTICES1